We are live on ! Find out more
MDGSW

Medigus Ltd. Series C Warrant
MDGSW

Delisted

MDGSW was delisted on the 19th of July, 2023.

Back to rankings

5 hedge funds and large institutions have $811K invested in Medigus Ltd. Series C Warrant in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $807K → $811K (+$4K)

0% more funds holding

Funds holding: 5 → 5 (0)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$2.01K

Top Sellers

1
WAM
Warberg Asset Management
Illinois
-$7.1K
2
CH
CVI Holdings
Delaware
-$1.23K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$745K – – –
AFM
2
Anson Funds Management
Texas
$33K – – –
CH
3
CVI Holdings
Delaware
$22K -$1.23K -2,500 -4%
WAM
4
Warberg Asset Management
Illinois
$9K -$7.1K -14,450 -44%
UBS Group
5
UBS Group
Switzerland
$2K +$2.01K +4,096 +509%

MDGSW Hedge Fund Activity: Q3 2021 in Review

5 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q3 2021, worth a combined $811K — up 0.5% from $807K a quarter earlier.

Fund positioning in MDGSW was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was UBS Group, adding an estimated $2.01K. The largest seller was Warberg Asset Management, cutting an estimated $7.1K.

  • 5 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $811K of Medigus Ltd. Series C Warrant stock for Q3 2021, up 0.5% quarter-over-quarter.
  • 0 funds opened new Medigus Ltd. Series C Warrant positions in Q3 2021 and 0 closed out.
  • The largest Medigus Ltd. Series C Warrant buyer in Q3 2021 was UBS Group, an estimated $2.01K added.
  • The largest Medigus Ltd. Series C Warrant seller in Q3 2021 was Warberg Asset Management, an estimated $7.1K sold.

Based on aggregated 13F filings for Q3 2021.